Skip to content

ARDX · NASDAQ

Ardelyx (ARDX) Stock Price & Fundamentals

$333.02+0.07%+$0.22End-of-day price as of Oct 9, 2026

Ardelyx (ARDX) closed at $333.02 on Oct 9, 2026, up 0.07% from the previous close of $332.80.

Share price, past year

1Y +11.77%

52-week range $281.49 – $341.41. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$333.02
Sep 30, 2026$340.97
Aug 31, 2026$317.47
Jul 31, 2026$302.24
Jun 30, 2026$315.72
May 29, 2026$306.20
Apr 30, 2026$316.05
Mar 31, 2026$321.90
Feb 27, 2026$327.15
Jan 30, 2026$305.92
Dec 31, 2025$289.75
Nov 28, 2025$282.48
Oct 31, 2025$291.97

Key statistics

Market cap
$82.97B
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
$450.89M
Net income (TTM)
−$55.70M
Shares outstanding
249.1M
Dividend yield
—
52-week range
$281.49 – $341.41

Ardelyx's market cap is $82.97B, based on a share price of $333.02 and 249.1M shares outstanding as of Jun 30, 2026.

Financials

Ardelyx reported revenue of $407.32M for fiscal 2025, up 22.09% from fiscal 2024.

Ardelyx reported a net loss of $61.60M in fiscal 2025.

Fiscal 2025 revenue was the highest in the 10 years shown.

Annual revenue

FY15FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Ardelyx annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$407.32M+22.1%−$61.60M−15.1%−$0.26−$43.98M
FY2024ended Dec 31, 2024$333.62M+168.1%−$39.14M−11.7%−$0.17−$45.82M
FY2023ended Dec 31, 2023$124.46M+138.6%−$66.07M−53.1%−$0.30−$90.06M
FY2022ended Dec 31, 2022$52.16M+416.6%−$67.21M−128.9%−$0.42−$70.10M
FY2021ended Dec 31, 2021$10.10M+33.4%−$158.17M−1,566.5%−$1.52−$154.42M
FY2020ended Dec 31, 2020$7.57M+43.4%−$94.31M−1,245.7%−$1.05−$81.76M
FY2019ended Dec 31, 2019$5.28M+102.6%−$94.94M−1,797.8%−$1.47−$76.81M
FY2018ended Dec 31, 2018$2.61M−93.8%−$91.30M−3,502.0%—−$70.59M
FY2017ended Dec 31, 2017$42.00M+74.8%−$64.34M−153.2%—−$67.55M
FY2015ended Dec 31, 2015$24.03M—————
Ardelyx quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$120.88M−$16.72M−$0.07
Q1 FY2026ended Mar 31, 2026$94.47M−$37.61M−$0.15
Q4 FY2025ended Dec 31, 2025$125.22M−$407.00K—
Q3 FY2025ended Sep 30, 2025$110.33M−$969.00K$0.00
Q2 FY2025ended Jun 30, 2025$97.66M−$19.08M−$0.08
Q1 FY2025ended Mar 31, 2025$74.11M−$41.14M−$0.17
Q4 FY2024ended Dec 31, 2024$116.13M$4.65M—
Q3 FY2024ended Sep 30, 2024$98.24M−$809.00K$0.00

Company profile

Name
Ardelyx, Inc.
Ticker
ARDX
Exchange
NASDAQ
Industry (SEC SIC)
Pharmaceutical Preparations
Headquarters
34175 Ardenwood Blvd., Fremont, CA 94555
Incorporated in
DE
Fiscal year ends
December
SEC CIK
0001437402

Recent SEC filings

Frequently asked questions

What is Ardelyx's stock price?

Ardelyx (ARDX) closed at $333.02 on Oct 9, 2026, up 0.07% from the previous close of $332.80.

What is Ardelyx's market cap?

Ardelyx's market cap is $82.97B, based on a share price of $333.02 and 249.1M shares outstanding as of Jun 30, 2026.

How much revenue does Ardelyx make?

Ardelyx reported revenue of $407.32M for fiscal 2025, up 22.09% from fiscal 2024.

Does Ardelyx pay a dividend?

Ardelyx's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from Ardelyx, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures